1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
2. Institute NC. SEER Stat Fact Sheets: acute myeloid leukemia (AML). National Cancer Institute, Bethesda, MD. 2015. http://seer.cancer.gov/statfacts/html/amyl.html . Accessed 26 April 2015.
3. Yates JW, Wallace HJ Jr, Ellison RR, Holland JF. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep Part 1. 1973;57(4):485–8.
4. Burnett AK. Treatment of acute myeloid leukemia: are we making progress? Hematol/Educ Program Am Soc Hematol Am Soc Hematol Educ Program. 2012;2012:1–6.
5. Derolf AR, Kristinsson SY, Andersson TM, Landgren O, Dickman PW, Bjorkholm M. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood. 2009;113(16):3666–72.